These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6268509)

  • 21. Endorphins, beta-LPH, and ACTH: biochemical, pharmacological and anatomical studies.
    Akil H; Watson SJ; Berger PA; Barchas JD
    Adv Biochem Psychopharmacol; 1978; 18():125-39. PubMed ID: 206107
    [No Abstract]   [Full Text] [Related]  

  • 22. Laboratory diagnosis of hypopituitarism.
    Abboud CF
    Mayo Clin Proc; 1986 Jan; 61(1):35-48. PubMed ID: 3001438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Corticotropic function of the pituitary gland in Cushing's syndrome treated with chloditane].
    Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Cheban AK
    Ter Arkh; 1978; 50(11):72-5. PubMed ID: 214890
    [No Abstract]   [Full Text] [Related]  

  • 24. [The studies for exacerbating factors of Cushing's syndrome during pregnancy, report of a case (author's transl)].
    Odagiri E; Demura H; Demura R; Nomura K; Hizuka N; Naruse M; Shizume K; Tanaka Y; Oouchi H
    Nihon Naika Gakkai Zasshi; 1981 Nov; 70(11):1573-80. PubMed ID: 6278034
    [No Abstract]   [Full Text] [Related]  

  • 25. Physiopathology of Cushing's disease.
    Krieger DT
    Endocr Rev; 1983; 4(1):22-43. PubMed ID: 6131818
    [No Abstract]   [Full Text] [Related]  

  • 26. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of atrial natriuretic factor on basal and stimulated pituitary-adrenal function in Cushing's and Addison's disease.
    Sala C; Ambrosi B; Colombo P; Ardeleani G; Bochicchio D; Gazzano G; Zanchetti A; Morganti A
    J Hypertens Suppl; 1993 Dec; 11(5):S312-3. PubMed ID: 8158401
    [No Abstract]   [Full Text] [Related]  

  • 28. [Characteristics of steroidogenesis and metabolism of corticosteroids in different forms of Cushing's disease].
    Cristoveanu A; Ciobanu D; Berceanu A; Stan M
    Stud Cercet Endocrinol; 1966; 17(3):257-68. PubMed ID: 4287864
    [No Abstract]   [Full Text] [Related]  

  • 29. Cushing's disease: clinical manifestations and diagnostic evaluation.
    Kirk LF; Hash RB; Katner HP; Jones T
    Am Fam Physician; 2000 Sep; 62(5):1119-27, 1133-4. PubMed ID: 10997535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cushing's Syndrome.
    Pivonello R; De Martino MC; De Leo M; Lombardi G; Colao A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):135-49, ix. PubMed ID: 18226734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypothalamo-hypophyseal Cushing's syndrome].
    Scriba PC; Müller OA; Fahlbusch R
    Verh Dtsch Ges Inn Med; 1980; 86():51-9. PubMed ID: 6261476
    [No Abstract]   [Full Text] [Related]  

  • 32. [Structure and properties of hypophyseal hormones. 1. Peptide hormones of the pituitary gland].
    Pankov IuA
    Probl Endokrinol (Mosk); 1974; 20(2):106-14. PubMed ID: 4364217
    [No Abstract]   [Full Text] [Related]  

  • 33. Human beta-endorphin: the real opium of the people?
    Br Med J; 1978 Jul; 2(6131):155-6. PubMed ID: 209845
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cushing's syndrome].
    Lucas Morante T
    Rev Clin Esp; 1994 Jan; 194(1):46-58. PubMed ID: 8153415
    [No Abstract]   [Full Text] [Related]  

  • 35. Opioid peptides and protein phosphorylation.
    Davis LG; Ehrlich YH
    Adv Exp Med Biol; 1979; 116():233-44. PubMed ID: 224672
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
    Martin R; Cetin Y; Fehm HL; Fahlbusch R; Voigt KH
    Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cushing's disease with corticotropic microadenoma and empty sella turcica].
    Leutenegger M; Gross A; Hublot C
    Nouv Presse Med; 1982 Feb; 11(6):454-5. PubMed ID: 6278400
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe hypertension secondary to renal artery stenosis and Cushing's syndrome.
    Alzahrani AS; Al-Hajjaj A; Al-Watban J; Kanaan I
    Saudi Med J; 2005 Apr; 26(4):668-73. PubMed ID: 15900383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of naloxone on the secretion of pituitary hormones in patients with acromegaly, microprolactinomas, Cushing's disease and Nelson's syndrome.
    Baranowska B; Jeske W; Misiorowski W; Dorobek W; Zgliczyński S
    Endokrynol Pol; 1986; 37(5):203-10. PubMed ID: 3830080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.